OpenAI has acquired Orchestra Bio, founded by Ashoka Rajendra, to expand its AI drug development push. By bringing Orchestra Bio’s technology together with its Rosalind tools, OpenAI hopes to help scientists manage drug research, track progress and develop new medicines more efficiently.

OpenAI has acquired Orchestra Bio, founded by Ashoka Rajendra, to expand its AI drug development push. By bringing Orchestra Bio’s technology together with its Rosalind tools, OpenAI hopes to help scientists manage drug research, track progress and develop new medicines more efficiently.